« Return to News | Awards & Advancement

Verasteam names Pachter VP, head of research

Thursday, August 4, 2011 01:11 PM

Verastem has named Jonathan Pachter, Ph.D., vice president and head of research.

Pachter joins Verastem with more than 20 years of experience discovery programs in small molecule and monoclonal antibody therapeutics for the treatment of cancer. He previously served as head of cancer biology at OSI Pharmaceuticals (acquired by Astellas). His team was responsible for the development of EMT (epithelial-mesenchymal transition) models to discover drugs that inhibit this process and the cancer stem cells that result. Pachter has an impressive record of successfully translating novel discoveries into the clinic for the treatment of cancer.

“Jon has been instrumental in progressing the science of EMT and cancer stem cells into the clinic,” said Robert Weinberg, Ph.D., Verastem co-founder and co-chair of the Scientific Advisory Board. “His ability to drive research will help Verastem deliver on the promise of new treatments for patients with incurable cancer.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.